199 related articles for article (PubMed ID: 25775920)
21. The Role of Regulatory Agencies and Intellectual Property: Part I.
Noonan KE
Cold Spring Harb Perspect Med; 2015 Mar; 5(7):a020800. PubMed ID: 25775921
[TBL] [Abstract][Full Text] [Related]
22. Economic analysis in health care antitrust.
Vita MG; Langenfeld J; Pautler P; Miller L
J Contemp Health Law Policy; 1991; 7():73-115. PubMed ID: 10111250
[TBL] [Abstract][Full Text] [Related]
23. Baby doe redux? The Department of Health and Human Services and the Born-Alive Infants Protection Act of 2002: a cautionary note on normative neonatal practice.
Sayeed SA
Pediatrics; 2005 Oct; 116(4):e576-85. PubMed ID: 16199687
[TBL] [Abstract][Full Text] [Related]
24. KSR v. Teleflex. Part 1: Impact of U.S Supreme Court Patent Law on Canadian intellectual property and regulatory rights landscape.
Bouchard RA
Health Law J; 2007; 15():221-46. PubMed ID: 19702184
[TBL] [Abstract][Full Text] [Related]
25. Antitrust and third party insurers.
Heitler G
Am J Law Med; 1982; 8(3):251-70. PubMed ID: 7168451
[TBL] [Abstract][Full Text] [Related]
26. Antitrust--pre-merger compliance.
Brock TH
Health Syst Rev; 1993; 26(6):36-8. PubMed ID: 10130173
[TBL] [Abstract][Full Text] [Related]
27. Supreme Court ruling may determine the future of state-based professionai licensing.
Owsiany DJ
J Am Coll Dent; 2014; 81(4):51-5. PubMed ID: 25975126
[TBL] [Abstract][Full Text] [Related]
28. Ruling upholds FTC's authority over non-profits.
Burda D
Mod Healthc; 1991 Aug; 21(31):3. PubMed ID: 10111896
[No Abstract] [Full Text] [Related]
29. Medical staff privileges and the antitrust laws: a view from the Federal Trade Commission.
Horoschak MJ
Med Staff Couns; 1992; 6(2):17-24. PubMed ID: 10116790
[TBL] [Abstract][Full Text] [Related]
30. Sharing, samples, and generics: an antitrust framework.
Carrier MA
Cornell Law Rev; 2017; 103(1):1-64. PubMed ID: 29236427
[TBL] [Abstract][Full Text] [Related]
31. The legal framework for effective competition.
Berenson RA; Hastings DA; Kopit WG
Baxter Health Policy Rev; 1996; 2():235-65. PubMed ID: 11066262
[TBL] [Abstract][Full Text] [Related]
32. Widespread implications. Phoebe Putney decision could affect future deals.
Carlson J
Mod Healthc; 2012 Dec; 42(49):26. PubMed ID: 23323309
[No Abstract] [Full Text] [Related]
33. The Federal Trade Commission and physician practice.
Graham J
J Med Pract Manage; 2005; 20(5):259-62. PubMed ID: 15921139
[TBL] [Abstract][Full Text] [Related]
34. Court denies rehearing on hospital sale. Tenet proceeds with deal; FTC could appeal to U.S. Supreme Court in antitrust challenge.
Taylor M
Mod Healthc; 1999 Oct; 29(41):10. PubMed ID: 10623215
[No Abstract] [Full Text] [Related]
35. FTC, Justice antitrust policies right on target.
Kenyon MK
Mod Healthc; 1996 Feb; 26(7):83. PubMed ID: 10154740
[No Abstract] [Full Text] [Related]
36. Changing antitrust prospects for hospital mergers.
O'Malley S
Health Syst Lead; 1997 Jan; 4(1):4-12. PubMed ID: 10164539
[TBL] [Abstract][Full Text] [Related]
37. Point/counterpoint: the proposed Grand Rapids merger.
O'Malley S
Health Syst Lead; 1997 Jan; 4(1):13-6. PubMed ID: 10164536
[TBL] [Abstract][Full Text] [Related]
38. COPAing with antitrust rules. Just three systems have used certificates of public advantage seeking antitrust immunity. Experts now say they're regulatory dinosaurs.
Taylor M
Mod Healthc; 2005 Feb; 35(8):30-2, 34. PubMed ID: 15765844
[No Abstract] [Full Text] [Related]
39. Antitrust law applicable to managed care contracting.
Weber RD
Mich Med; 1995 Apr; 94(4):16-7. PubMed ID: 7791633
[TBL] [Abstract][Full Text] [Related]
40. Strategies for strengthening patent protection of pharmaceutical inventions in light of federal court decisions.
Pillai X; Kinney WA
Curr Top Med Chem; 2010; 10(18):1929-36. PubMed ID: 20615184
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
